Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1991;83:1698-1704

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wennmalm, A.
Right arrow Articles by Winell, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wennmalm, A.
Right arrow Articles by Winell, S.

Circulation, Vol 83, 1698-1704, Copyright © 1991 by American Heart Association


ARTICLES

Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men

A Wennmalm, G Benthin, EF Granstrom, L Persson, AS Petersson and S Winell
Department of Clinical Physiology, Gothenburg University, Sweden.

BACKGROUND. Cigarette smoking is a risk factor for cardiovascular disease. The present study addressed the effect of tobacco use on the formation of two eicosanoids, thromboxane A2 and prostacyclin, which have been implicated in both acute and chronic cardiovascular disorders. METHODS AND RESULTS. In 577 randomly sampled 18-19-year-old men, the urinary excretion of the 2,3-dinor metabolites of thromboxane A2 and prostacyclin (Tx-M and PGI-M, respectively) was analyzed and related to the subjects' self-reported use of tobacco. Sixty-five percent of the subjects used no tobacco, 7.5% were cigarette smokers, 22% used wet (oral) snuff, and the rest reported a mixed use of tobacco. The urinary excretion of Tx-M was higher (p less than 0.001) in cigarette smokers than in those not using tobacco (180 versus 128 pg/mg creatinine) and was correlated (r = 0.35, p less than 0.05) with the daily cigarette consumption. Snuff users had no increase in their urinary excretion of Tx-M, despite urinary cotinine levels comparable to those in the cigarette smokers (1,210 and 1,560 ng/ml, respectively). The excretion of PGI-M did not differ between non- tobacco users, cigarette smokers, and snuff users. CONCLUSIONS. We conclude that cigarette smoking, but not the use of snuff, facilitates the formation of thromboxane A2. We propose that such an increased formation reflects platelet activation in the absence of vascular injury and that it may be of significance for the subsequent development of cardiovascular disease.


This article has been cited by other articles:


Home page
HypertensionHome page
A. Gamboa, C. Shibao, A. Diedrich, S. Y. Paranjape, G. Farley, B. Christman, S. R. Raj, D. Robertson, and I. Biaggioni
Excessive Nitric Oxide Function and Blood Pressure Regulation in Patients With Autonomic Failure
Hypertension, June 1, 2008; 51(6): 1531 - 1536.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. K. Tong and S. A. Glantz
Tobacco Industry Efforts Undermining Evidence Linking Secondhand Smoke With Cardiovascular Disease
Circulation, October 16, 2007; 116(16): 1845 - 1854.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
P. N Lee
Circulatory disease and smokeless tobacco in Western populations: a review of the evidence
Int. J. Epidemiol., August 1, 2007; 36(4): 789 - 804.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
R. Gupta, H. Gurm, and J. R. Bartholomew
Smokeless Tobacco and Cardiovascular Risk
Arch Intern Med, September 27, 2004; 164(17): 1845 - 1849.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. C. Yugar-Toledo, J. E. Tanus-Santos, M. Sabha, M. G. Sousa, M. Cittadino, L. H. B. Tacito, and H. Moreno Jr.
Uncontrolled Hypertension, Uncompensated Type II Diabetes, and Smoking Have Different Patterns of Vascular Dysfunction
Chest, March 1, 2004; 125(3): 823 - 830.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. L. Benowitz
Basic cardiovascular research and its implications for the medicinal use of nicotine
J. Am. Coll. Cardiol., February 5, 2003; 41(3): 497 - 498.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Zevin, S. Saunders, S. G. Gourlay, P. Jacob III, and N. L. Benowitz
Cardiovascular effects of carbon monoxide and cigarette smoking
J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1633 - 1638.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
J. Sztajzel, F. Mach, and A. Righetti
Current concepts in medicine: Role of the vascular endothelium in patients with angina pectoris or acute myocardial infarction with normal coronary arteries
Postgrad. Med. J., January 1, 2000; 76(891): 16 - 21.
[Abstract] [Full Text]


Home page
ADRHome page
N.L. Benowitz
Systemic Absorption and Effects of Nicotine From Smokeless Tobacco
Advances in Dental Research, September 1, 1997; 11(3): 336 - 341.
[Abstract] [PDF]


Home page
CirculationHome page
T. Heitzer, S. Yla-Herttuala, J. Luoma, S. Kurz, T. Munzel, H. Just, M. Olschewski, and H. Drexler
Cigarette Smoking Potentiates Endothelial Dysfunction of Forearm Resistance Vessels in Patients With Hypercholesterolemia : Role of Oxidized LDL
Circulation, April 1, 1996; 93(7): 1346 - 1353.
[Abstract] [Full Text]